IRCT20181019041385N1 IRCT 2019-10-28 The university of kurdestan Comparision of the efficacy of pharmacotherapy and combination of pharmacotherapy with transdiagnostic cognitive-behavior therapy on anxiety and depression symptoms in patients with emotional disorders Comparision of the efficacy of pharmacotherapy and combination of pharmacotherapy with transdiagnostic cognitive-behavior therapy on anxiety and depression symptoms in patients with emotional disorders 2018-11-11 anticipated 29 Complete https://irct.ir/trial/34815 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Diagnostic. 3 Anxiety disorders and complex depression. Intervention 1: In the present study, participants were taking Anti-anxiety and antidepressant medication(Such as serotonin, Clonazepam, Buspirone, and venlafaxine) and also received eight sessions of transdiagnostic cognitive-behavioral therapy. Session 2: Psychological Training and Emotion Recognition. Session 3: Emotional Awareness Training.Session 4: Cognitive Assessment and Reassessment. Session 5: Emotional Avoidance (Behavior Understanding). Session 6: Emotional Behavior Behaviors (EDBs) Session 7: Exposure to Physical Sensations. Intervention 2: Control group: only anti-anxiety and anti-depressant drugs they consume. Yes - There is a plan to make this available What will be shared: The data will be provided after it is completed. When: Information will be provided up to 5 months after the defense. To whom: Under the guidance of the supervisor, information will be provided. Conditions: For the scientific use and promotion of knowledge. Where to obtain: From the Supervisor Dr. Mehdi zemestany. How to obtain: Information will be provided up to 5 months after the defense. Comments: